(Q43745656)
Statements
1 reference
Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells (English)
1 reference
Sameena Khan
1 reference
Deborah J Burt
1 reference
Robert E Hawkins
1 reference
5 November 2010
1 reference
1 reference
138
1 reference
1
1 reference
85-96
1 reference
Identifiers
1 reference
1 reference